Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 209

1.

Quantitative fluorescent profiling of VEGFRs reveals tumor cell and endothelial cell heterogeneity in breast cancer xenografts.

Imoukhuede PI, Popel AS.

Cancer Med. 2014 Apr;3(2):225-44. doi: 10.1002/cam4.188. Epub 2014 Jan 22.

PMID:
24449499
[PubMed - in process]
Free PMC Article
2.

A bioimage informatics based reconstruction of breast tumor microvasculature with computational blood flow predictions.

Stamatelos SK, Kim E, Pathak AP, Popel AS.

Microvasc Res. 2014 Jan;91:8-21. doi: 10.1016/j.mvr.2013.12.003. Epub 2013 Dec 14.

PMID:
24342178
[PubMed - in process]
3.

Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning.

Vempati P, Popel AS, Mac Gabhann F.

Cytokine Growth Factor Rev. 2014 Feb;25(1):1-19. doi: 10.1016/j.cytogfr.2013.11.002. Epub 2013 Nov 27.

PMID:
24332926
[PubMed - in process]
4.

A systems biology view of blood vessel growth and remodelling.

Logsdon EA, Finley SD, Popel AS, Gabhann FM.

J Cell Mol Med. 2013 Nov 17. doi: 10.1111/jcmm.12164. [Epub ahead of print]

PMID:
24237862
[PubMed - as supplied by publisher]
5.

Computational model of VEGFR2 pathway to ERK activation and modulation through receptor trafficking.

Tan WH, Popel AS, Mac Gabhann F.

Cell Signal. 2013 Dec;25(12):2496-510. doi: 10.1016/j.cellsig.2013.08.015. Epub 2013 Aug 29.

PMID:
23993967
[PubMed - in process]
6.

Pre-treatment of mice with tumor-conditioned media accelerates metastasis to lymph nodes and lungs: a new spontaneous breast cancer metastasis model.

Lee E, Pandey NB, Popel AS.

Clin Exp Metastasis. 2014 Jan;31(1):67-79. doi: 10.1007/s10585-013-9610-9. Epub 2013 Aug 21.

PMID:
23963763
[PubMed - indexed for MEDLINE]
7.

Compartment model predicts VEGF secretion and investigates the effects of VEGF trap in tumor-bearing mice.

Finley SD, Dhar M, Popel AS.

Front Oncol. 2013 Jul 30;3:196. doi: 10.3389/fonc.2013.00196. eCollection 2013.

PMID:
23908970
[PubMed]
Free PMC Article
8.

Long-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptide.

Shmueli RB, Ohnaka M, Miki A, Pandey NB, Lima e Silva R, Koskimaki JE, Kim J, Popel AS, Campochiaro PA, Green JJ.

Biomaterials. 2013 Oct;34(30):7544-51. doi: 10.1016/j.biomaterials.2013.06.044. Epub 2013 Jul 10.

PMID:
23849876
[PubMed - indexed for MEDLINE]
9.

Computational Model of Gab1/2-Dependent VEGFR2 Pathway to Akt Activation.

Tan WH, Popel AS, Mac Gabhann F.

PLoS One. 2013 Jun 21;8(6):e67438. Print 2013.

PMID:
23805312
[PubMed - as supplied by publisher]
Free PMC Article
10.

Effect of tumor microenvironment on tumor VEGF during anti-VEGF treatment: systems biology predictions.

Finley SD, Popel AS.

J Natl Cancer Inst. 2013 Jun 5;105(11):802-11. doi: 10.1093/jnci/djt093. Epub 2013 May 13.

PMID:
23670728
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Inhibition of lymphangiogenesis and angiogenesis in breast tumor xenografts and lymph nodes by a peptide derived from transmembrane protein 45A.

Lee E, Koskimaki JE, Pandey NB, Popel AS.

Neoplasia. 2013 Feb;15(2):112-24.

PMID:
23441126
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Endothelial cell-by-cell profiling reveals the temporal dynamics of VEGFR1 and VEGFR2 membrane localization after murine hindlimb ischemia.

Imoukhuede PI, Dokun AO, Annex BH, Popel AS.

Am J Physiol Heart Circ Physiol. 2013 Apr 15;304(8):H1085-93. doi: 10.1152/ajpheart.00514.2012. Epub 2013 Feb 1.

PMID:
23376830
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Synergy between a collagen IV mimetic peptide and a somatotropin-domain derived peptide as angiogenesis and lymphangiogenesis inhibitors.

Koskimaki JE, Lee E, Chen W, Rivera CG, Rosca EV, Pandey NB, Popel AS.

Angiogenesis. 2013 Jan;16(1):159-70. doi: 10.1007/s10456-012-9308-7. Epub 2012 Sep 29.

PMID:
23053781
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Effects of fiber type and size on the heterogeneity of oxygen distribution in exercising skeletal muscle.

Liu G, Mac Gabhann F, Popel AS.

PLoS One. 2012;7(9):e44375. doi: 10.1371/journal.pone.0044375. Epub 2012 Sep 18.

PMID:
23028531
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Expression of VEGF receptors on endothelial cells in mouse skeletal muscle.

Imoukhuede PI, Popel AS.

PLoS One. 2012;7(9):e44791. doi: 10.1371/journal.pone.0044791. Epub 2012 Sep 12.

PMID:
22984559
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Constructing the angiome: a global angiogenesis protein interaction network.

Chu LH, Rivera CG, Popel AS, Bader JS.

Physiol Genomics. 2012 Oct 2;44(19):915-24. doi: 10.1152/physiolgenomics.00181.2011. Epub 2012 Aug 21.

PMID:
22911453
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Multiscale imaging and computational modeling of blood flow in the tumor vasculature.

Kim E, Stamatelos S, Cebulla J, Bhujwalla ZM, Popel AS, Pathak AP.

Ann Biomed Eng. 2012 Nov;40(11):2425-41. doi: 10.1007/s10439-012-0585-5. Epub 2012 May 8. Review.

PMID:
22565817
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Predicting the effects of anti-angiogenic agents targeting specific VEGF isoforms.

Finley SD, Popel AS.

AAPS J. 2012 Sep;14(3):500-9. doi: 10.1208/s12248-012-9363-4. Epub 2012 May 1.

PMID:
22547351
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Serpin-derived peptides are antiangiogenic and suppress breast tumor xenograft growth.

Koskimaki JE, Rosca EV, Rivera CG, Lee E, Chen W, Pandey NB, Popel AS.

Transl Oncol. 2012 Apr;5(2):92-7. Epub 2012 Apr 1.

PMID:
22496925
[PubMed]
Free PMC Article
20.

Collagen IV and CXC chemokine-derived antiangiogenic peptides suppress glioma xenograft growth.

Rosca EV, Lal B, Koskimaki JE, Popel AS, Laterra J.

Anticancer Drugs. 2012 Aug;23(7):706-12. doi: 10.1097/CAD.0b013e3283531041.

PMID:
22495619
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk